Atomo Diagnostics (ASX:AT1) has secured a purchase order from UK-based diagnostics company Newfoundland Diagnostics worth approximately $900,000 for its HIV products.
Atomo Diagnostics anticipates this will be the first of many orders and are working to rapidly conclude a comprehensive agreement for supply of its products to Newfoundland for the European market.
The company says Newfoundland has established extensive distribution networks in Europe across public health, pharmacy, and retail channels.
Atomo Diagnostics has also terminated the HIV distribution agreement covering the UK and other European markets previously entered into with Owen Mumford.